Clinical Research Directory
Browse clinical research sites, groups, and studies.
SCLife®-UT hUC-MSCs Advanced Therapy Medicinal Products (hUC-MSCs ATMPs) for Patients With Thin Endometrial Infertility
Sponsor: Sclnow Biotechnology Co., Ltd.
Summary
To explore the therapeutic effect and safety of human umbilical cord mesenchymal stem cells on thin endometrial infertility and to explore whether human umbilical cord mesenchymal stem cells using collagen as the carrier can promote endometrial growth, reduce the recurrence rate of intrauterine adhesion, increase the clinical pregnancy rate, improve the pregnancy outcome, and study its safety.
Official title: A Clinical Research on SCLife®-UT hUC-MSCs Advanced Therapy Medicinal Products (hUC-MSCs ATMPs) for Patients With Thin Endometrial Infertility
Key Details
Gender
FEMALE
Age Range
20 Years - 39 Years
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2026-12-31
Completion Date
2027-12-31
Last Updated
2026-04-23
Healthy Volunteers
No
Conditions
Interventions
human umbilical cord mesenchymal stem cell complex collagen
1 \* 10\^7 cells (2ml)
intrauterine injection
intrauterine injection with human umbilical cord mesenchymal stem cell (19#iSCLife®-UT); total 1 time
Locations (1)
Changsha Reproductive Medicine Hospital (Changsha Ning 'er Maternity Hospital)
Changsha, Hunan, China